Circulating leptin and thyroid dysfunction

European Journal of Endocrinology

Volumn 149, Issue 4, 2003, Pages 257-271

  Zimmermann Belsing, Tina ^c   Brabant, Georg ^a   Holst, Jens Juul ^b   Feldt Rasmussen, Ulla ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; LEPTIN RECEPTOR; LIOTHYRONINE; MELANOCORTIN; MITOCHONDRIAL PROTEIN; THYROID HORMONE; THYROXINE; UNCOUPLING PROTEIN;

AUTOIMMUNITY; BODY COMPOSITION; BODY WEIGHT; DISEASE SEVERITY; FOOD INTAKE; GENE SEQUENCE; HORMONE ACTION; HUMAN; HYPERTHYROIDISM; HYPOPHYSIS THYROID SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MOLECULAR MECHANICS; MYXEDEMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; RAT; REVIEW; SIGNAL TRANSDUCTION; STARVATION; STRUCTURE ANALYSIS; THERMOGENESIS; THYROID DISEASE; THYROTOXICOSIS;

ANIMALS; BIOLOGICAL TRANSPORT; BODY COMPOSITION; BRAIN; HUMANS; LEPTIN; RECEPTORS, CELL SURFACE; THERMOGENESIS; THYROID DISEASES; THYROID GLAND; THYROID HORMONES;

EID: 0142216508     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1490257     Document Type: Review

References (94)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L & Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994 372 425-432.
2. Auwerx J & Staels B. Leptin. Lancet 1998 351 737-742.
3. Campfield LA, Smith FJ, Guisez Y, Devos R & Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks [see comments]. Science 1995 269 546-549.
4. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995 269 543-546.
5. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995 269 540-543.
6. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ & Baskin DG. Central nervous system control of food intake. Nature 2000 404 661-671.
7. Mantzoros CS & Moschos SJ. Leptin: in search of role(s) in human physiology and pathophysiology. Clinical Endocrinology 1998 49 551-567.
8. Fruhbeck G, Jebb SA & Prentice AM. Leptin: physiology and pathophysiology. Clinical Physiology 1998 18 399-419.
9. Flier JS, Harris M & Hollenberg AN. Leptin, nutrition, and the thyroid: the why, the wherefore, and the wiring. Journal of Clinical Investigation 2000 105 859-861.
10. Zhang F, Basinski MB, Beals JM, Briggs SL, Churgay LM, Clawson DK et al. Crystal structure of the obese protein leptin-E100. Nature 1997 387 206-209.
11. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995 83 1263-1271.
12. De Matteis R, Dashtipour K, Ognibene A & Cinti S. Localization of leptin receptor splice variants in mouse peripheral tissues by immunohistochemistry. Proceedings of the Nutrition Society 1998 57 441-448.
13. Marti A, Berraondo B & Martinez JA. Leptin: physiological actions. Journal of Physiology and Biochemistry 1999 55 43-49.
14. Nowak KW. Kaczmarek P, Mackowiak P, Ziolkowska A, Albertin G, Ginda WJ et al. Rat thyroid gland expresses the long form of leptin receptors, and leptin stimulates the function of the gland in euthyroid non-fasted animals. International Journal of Molecular Medicine 2002 9 31-34.
15. Caro JF. Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH et al. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance [see comments]. Lancet 1996 348 159-161.
16. Schwartz MW. Peskind E, Raskind M, Boyko EJ & Porte D Jr. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nature Medicine 1996 2 589-593.
17. Houseknecht KL, Mantzoros CS, Kuliawat R, Hadro E, Flier JS & Kahn BB. Evidence for leptin binding to proteins in serum of rodents and humans: modulation with obesity. Diabetes 1996 45 1638-1643.
18. Sinha MK, Opentanova I, Ohannesian JP, Kolaczynski JW, Heiman ML, Hale J et al. Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. Journal of Clinical Investigation 1996 98 1277-1282.
19. Brabant G, Horn R, Von zur Muhlen A, Mayr B, Wurster U, Heidenreich F et al. Free and protein bound leptin are distinct and independently controlled factors in energy regulation. Diabetologia 2000 43 438-442.
20. Widjaja A, Hofmann R, Bruhn J, Von zur Muhlen A & Brabant G. Free and bound leptin levels during human pregnancy. Gynecology and Endocrinology 2000 14 264-269.
21. Randeva HS. Murray RD, Lewandowski KC, O'Callaghan CJ, Horn R, O'Hare P et al. Differential effects of GH replacement on the components of the leptin system in GH-deficient individuals. Journal of Clinical Endocrinology and Metabolism 2002 87 798-804.
22. Ockenga J, Bischoff SC,Tillmann HL, Rifai K, Widjaja A, Boker KH et al. Elevated bound leptin correlates with energy expenditure in cirrhotics. Gastroenterology 2000 119 1656-1662.
23. Licinio J, Mantzoros C, Negrao AB, Cizza G, Wong ML, Bongiorno PB et al. Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nature Medicine 1997 3 575-579.
24. Licinio J, Negrao AB, Mantzoros C, Kaklamani V, Wong ML, Bongiorno PB et al. Synchronicity of frequently sampled, 24-h concentrations of circulating leptin, luteinizing hormone, and estradiol in healthy women. PNAS 1998 95 2541-2546.
25. Fekete C, Kelly J, Mihaly E, Sarkar S, Rand WM, Legradi G et al. Neuropeptide Y has a central inhibitory action on the hypothalamic-pituitary-thyroid axis. Endocrinology 2001 142 2606-2613.
26. Fekete C, Legradi G, Mihaly E, Huang QH, Tatro JB, Rand WM et al. α-Melanocyte-stimulating hormone is contained in nerve terminals innervating thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and prevents fasting-induced suppression of prothyrotropin-releasing hormone gene expression. Journal of Neuroscience 2000 20 1550-1558.
27. Legradi G, Emerson CH, Ahima RS, Rand WM, Flier JS & Lechan RM. Arcuate nucleus ablation prevents fasting-induced suppression of ProTRH mRNA in the hypothalamic paraventricular nucleus. Neuroendocrinology 1998 68 89-97.
28. Kim MS, Small CJ, Stanley SA, Morgan DG, Seal LJ, Kong WM et al. The central melanocortin system affects the hypothalamo-pituitary-thyroid axis and may mediate the effect of leptin. Journal of Clinical Investigation 2000 105 1005-1011.
29. Lowell BB & Spiegelman BM. Towards a molecular understanding of adaptive thermogenesis. Nature 2000 404 652-660.
30. Leibel RL, Rosenbaum M & Hirsch J. Changes in energy expenditure resulting from altered body weight. New England Journal of Medicine 1995 332 621-628.
31. Klingenberg M & Huang SG. Structure and function of the uncoupling protein from brown adipose tissue. Biochimica et Biophysica Acta 1999 1415 271-296.
32. Nicholls DG & Locke RM. Thermogenic mechanisms in brown fat. Physiological Reviews 1984 64 1-64.
33. Fleury C, Neverova M, Collins S, Raimbault S, Champigny O, Levi-Meyrueis C et al. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia [see comments]. Nature Genetics 1997 15 269-272.
34. Gimeno RE, Dembski M, Weng X, Deng N, Shyjan AW, Gimeno CJ et al. Cloning and characterization of an uncoupling protein homolog: a potential molecular mediator of human thermogenesis. Diabetes 1997 46 900-906.
35. Gong DW, He Y, Karas M & Reitman M. Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, beta3-adrenergic agonists, and leptin. Journal of Biological Chemistry 1997 272 24129-24132.
36. Zhang CY, Hagen T, Mootha VK, Slieker LJ & Lowell BB. Assessment of uncoupling activity of uncoupling protein 3 using a yeast heterologous expression system. FEBS Letters 1999 449 129-134.
37. Landsherg L, Saville ME & Young JB. Sympathoadrenal system and regulation of thermogenesis. American Journal of Physiology 1984 247 E181-E189.
38. Himms-Hagen J. Brown adipose tissue thermogenesis and obesity. Progress in Lipid Research 1989 28 67-115.
39. Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA & Surwit RS. Role of leptin in fat regulation [letter]. Nature 1996 380 677.
40. Haynes WG, Morgan DA, Walsh SA, Mark AL & Sivitz WI. Receptor-mediated regional sympathetic nerve activation by leptin. Journal of Clinical Investigation 1997 100 270-278.
41. Champigny O & Ricquier D. Effects of fasting and refeeding on the level of uncoupling protein mRNA in rat brown adipose tissue: evidence for diet-induced and cold-induced responses. Journal of Nutrition 1990 120 1730-1736.
42. Melnyk A & Himms-Hagen J. Temperature-dependent feeding: lack of role for leptin and defect in brown adipose tissue-ablated obese mice. American Journal of Physiology 1998 274 R1131-R1135.
43. Silva JE. Thyroid hormone control of thermogenesis and energy balance. Thyroid 1995 5 481-492.
44. Syed MA, Thompson MP, Pachucki J & Burmeister LA. The effect of thyroid hormone on size of fat depots accounts for most of the changes in leptin mRNA and serum levels in the rat. Thyroid 1999 9 503-512.
45. Cusin I, Rouru J, Visser T, Burger AG & Rohner-Jeanrenaud F. Involvement of thyroid hormones in the effect of intracerebroventricular leptin infusion on uncoupling protein-3 expression in rat muscle. Diabetes 2000 49 1101-1105.
46. Gong DW, Monemdjou S, Gavrilova O, Leon LR, Marcus-Samuels B, Chou CJ et al. Lack of obesity and normal response to fasting and thyroid hormone in mice lacking uncoupling protein-3. Journal of Biological Chemistry 2000 275 16251-16255.
47. Lonnqvist F, Arner P, Nordfors L & Schalling M. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nature Medicine 1995 1 950-953.
48. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. New England Journal of Medicine 1996 334 292-295.
49. Rosenbaum M, Nicolson M, Hirsch J, Heymsfield SB, Gallagher D, Chu F et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. Journal of Clinical Endocrinology and Metabolism 1996 81 3424-3427.
50. Sinha MK. Human leptin: the hormone of adipose tissue. European Journal of Endocrinology 1997 136 461-464.
51. Zimmermann-Belsing T, Dreyer M, Holst JJ & Feldt-Rasmussen U. The relationship between the serum leptin concentrations of thyrotoxic patients during treatment and their total fat mass is different from that of normal subjects. Clinical Endocrinology 1998 49 589-595.
52. Ohguni S, Notsu K & Kato Y. Correlation of plasma free thyroxine levels with insulin sensitivity and metabolic clearance rate of insulin in patients with hyperthyroid Graves' disease. Internal Medicine 1995 34 339-341.
53. Bech K, Damsbo P, Eldrup E, Beck-Nielsen H, Roder ME, Hartling SG et al. Beta-cell function and glucose and lipid oxidation in Graves' disease. Clinical Endocrinology 1996 44 59-66.
54. Lewandowski K, Randeva HS, O'Callaghan CJ, Horn R, Medley GF, Hillhouse EW et al. Effects of insulin and glucocorticoids on the leptin system are mediated through free leptin. Clinical Endocrinology 2001 54 533-539.
55. Jensen MD, Hensrud D, O'Brien PC & Nielsen S. Collection and interpretation of plasma leptin concentration data in humans. Obesity Research 1999 7 241-245.
56. Lonn L, Stenlof K, Ottosson M, Lindroos AK, Nystrom E & Sjostrom L. Body weight and body composition changes after treatment of hyperthyroidism. Journal of Clinical Endocrinology and Metabolism 1998 83 4269-4273.
57. Fain JN, Coronel EC, Beauchamp MJ & Bahouth SW. Expression of leptin and beta 3-adrenergic receptors in rat adipose tissue in altered thyroid states. Biochemical Journal 1997 322 145-150.
58. Escobar-Morreale HF, Escobar del Rey F & Morreale de Escobar G. Thyroid hormones influence serum leptin concentrations in the rat. Endocrinology 1997 138 4485-4488.
59. Fain JN & Bahouth SW. Effect of tri-iodothyronine on leptin release and leptin mRNA accumulation in rat adipose tissue. Biochemical Journal 1998 332 361-366.
60. Curcio C, Lopes AM, Ribeiro MO, Francoso CA Jr, Carvalho SD, Lima FB et al. Development of compensatory thermogenesis in response to overfeeding in hypothyroid rats. Endocrinology 1999 140 3438-3443.
61. Wang JL, Chinookoswong N, Yin S & Shi ZQ. Calorigenic actions of leptin are additive to, but not dependent on, those of thyroid hormones. American Journal of Physiology, Endocrinology and Metabolism 2000 279 E1278-E1285.
62. Iossa S, Lionetti L, Mollica MP, Crescenzo R, Barletta A & Liverini G. Fat balance and serum leptin concentrations in normal, hypothyroid, and hyperthyroid rats. International Journal of Obesity and Related Metabolic Disorders 2001 25 417-425.
63. Corbetta S, Englaro P, Giambona S, Persani L, Blum WF & Beck-Peccoz P. Lack of effects of circulating thyroid hormone levels on serum leptin concentrations. European Journal of Endocrinology 1997 137 659-663.
64. Mantzoros CS, Rosen HN, Greenspan SL, Flier JS & Moses AC. Short-term hyperthyroidism has no effect on leptin levels in man. Journal of Clinical Endocrinology and Metabolism 1997 82 497-499.
65. Sreenan S, Caro JF & Refetoff S. Thyroid dysfunction is not associated with alterations in serum leptin levels. Thyroid 1997 7 407-409.
66. Valcavi R, Zini M, Peino R, Casanueva FF & Dieguez C. Influence of thyroid status on serum immunoreactive leptin levels. Journal of Clinical Endocrinology and Metabolism 1997 82 1632-1634.
67. Wolthers T, Lechuga A, Grofte T, Norrelund H, Moller N, Christiansen JS et al. Serum leptin concentrations during short-term administration of growth hormone and triiodothyronine in healthy adults: a randomised, double-blind placebo-controlled study. Hormone and Metabolic Research 1999 31 37-40.
68. Sesmilo G, Casamitjana R, Halperin I, Gomis R & Vilardell E. Role of thyroid hormones on serum leptin levels. European Journal of Endocrinology 1998 139 428-430.
69. Yoshida T, Momotani N, Hayashi M, Monkawa T, Ito K & Saruta T. Serum leptin concentrations in patients with thyroid disorders. Clinical Endocrinology 1998 48 299-302.
70. Ozata M, Ozisik G, Bingol N, Corakci A & Gundogan MA. The effects of thyroid status on plasma leptin levels in women. Journal of Endocrinological Investigation 1998 21 337-341.
71. Leonhardt U, Ritzel U, Schafer G, Becker W & Ramadori G. Serum leptin levels in hypo- and hyperthyroidism. Journal of Endocrinology 1998 157 75-79.
72. Pinkney JH, Goodrick SJ, Katz J, Johnson AB, Lightman SL, Coppack SW et al. Leptin and the pituitary-thyroid axis: a comparative study in lean, obese, hypothyroid and hyperthyroid subjects. Clinical Endocrinology 1998 49 583-588.
73. Diekman MJ, Romijn JA, Endert E, Sauerwein H & Wiersinga WM. Thyroid hormones modulate serum leptin levels: observations in thyrotoxic and hypothyroid women. Thyroid 1998 8 1081-1086.
74. Kristensen K, Pedersen SB, Langdahl BL & Richelsen B. Regulation of leptin by thyroid hormone in humans: studies in vivo and in vitro. Metabolism 1999 48 1603-1607.
75. Miyakawa M, Tsushima T, Murakami H, Isozaki O & Takano K. Serum leptin levels and bioelectrical impedance assessment of body composition in patients with Graves' disease and hypothyroidism. Endocrine Journal 1999 46 665-673.
76. Kautzky-Willer A, Ludwig C, Nowotny P, Roden A, Huemer C, Widhalm K et al. Elevation of plasma leptin concentrations in obese hyperinsulinaemic hypothyroidism before and after treatment. European Journal of Clinical Investigation 1999 29 395-403.
77. Song YM, Shen WH, Lee WJ, Wu CJ & Kao CH. Plasma leptin concentrations are related to body fat mass and gender but not to thyroid dysfunction. Kaohsiung Journal of Medical Science 1999 15 119-126.
78. Asami T, Ciomarten T & Uchiyama M. Relationship between serum leptin and thyroid hormones in children. Pediatrica International 2000 42 293-295.
79. Chen MD, Song YM, Tsou CT, Lin WH & Sheu WH. Leptin concentration and the Zn/Cu ratio in plasma in women with thyroid disorder. Biological Trace Element Research 2000 75 99-105.
80. Simo R, Hernandez C, Zafon C, Galofre P, Castellanos JM & Mesa J. Short-term hypothyroidism has no effect on serum leptin concentrations. Diabetes, Obesity and Metabolism 2000 2 317-321.
81. Sera N, Yokoyama N, Abe Y, Ide A, Imaizumi M, Usa T et al. Thyroid hormones influence serum leptin levels in patients with Graves' disease during suppression of beta-adrenergic receptors. Thyroid 2000 10 641-646.
82. Song YM, Lee WJ, Chen MD, Kao CH & Sheu WH. Methylprednisolone increases plasma leptin levels in Graves' hyperthyroidism patients with active Graves' ophthalmopathy. Hormone Metabolic Research 2000 32 277-282.
83. Pinkney JH, Goodrick SJ, Katz JR, Johnson AB, Lightman SL, Coppack SW et al. Thyroid and sympathetic influences on plasma leptin in hypothyroidism and hyperthyroidism. International Journal of Obesity and Related Metabolic Disorders 2000 24 (Suppl 2) S165-S166.
84. Nakamura T, Nagasaka S, Ishikawa S, Hayashi H, Saito T, Kusaka I et al. Association of hyperthyroidism with serum leptin levels. Metabolism 2000 49 1285-1288.
85. Matsubara M, Yoshizawa T, Morioka T & Katayose S. Serum leptin and lipids in patients with thyroid dysfunction. Journal of Atherosclerosis and Thrombosis 2000 7 50-54.
86. Ozata M, Uckaya G, Bolu E, Corapcioglu D, Bingol N & Ozdemir IC. Plasma leptin concentrations in patients with Graves' disease with or without ophthalmopathy. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 2001 7 696-700.
87. Seven R. Thyroid status and leptin in Basedow-Graves and multinodular goiter patients. Journal of Toxicology and Environmental Health Part A 2001 63 575-581.
88. Obermayer-Pietsch BM, Fruhauf GE, Lipp RW, Sendlhofer G & Pieber TR. Dissociation of leptin and body weight in hyperthyroid patients after radioiodine treatment. International Journal of Obesity and Related Metabolic Disorders 2001 25 115-120.
89. Hsieh CJ, Wang PW, Wang ST, Liu RT, Tung SC, Chien WY et al. Serum leptin concentrations of patients with sequential thyroid function changes. Clinical Endocrinology 2002 57 29-34.
90. Masaki T, Yoshimatsu H, Kakuma T, Hidaka S, Kurokawa M & Sakata T. Enhanced expression of uncoupling protein 2 gene in rat white adipose tissue and skeletal muscle following chronic treatment with thyroid hormone. FEBS Letters 1997 418 323-326.
91. Erickson DZ, Harteneck DA, Erickson BJ, Dutton CM & Bahn RS. Induction of leptin expression in orbital preadipocyte fibroblasts. Thyroid 2001 11 221-226.
92. Yoshida T, Monkawa T, Hayashi M & Saruta T. Regulation of expression of leptin mRNA and secretion of leptin by thyroid hormone in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications 1997 232 822-826.
93. Considine RV & Caro JF. Leptin and the regulation of body weight. International Journal of Biochemistry and Cell Biology 1997 29 1255-1272.
94. Zarkesh-Esfahani H, Pockley G, Metcalfe RA, Bidlingmaier M, Wu Z, Ajami A et al. High-dose leptin activates human leukocytes via receptor expression on monocytes. Journal of Immunology 2001 167 4593-4599.